Detalles de la búsqueda
1.
Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study.
Cost Eff Resour Alloc
; 22(1): 42, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38769560
2.
A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure.
BMC Nephrol
; 24(1): 47, 2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890464
3.
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain.
Expert Rev Pharmacoecon Outcomes Res
; 24(2): 227-235, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126738
4.
Epidemiology and risk factors for hyperkalaemia in heart failure.
ESC Heart Fail
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38439165
5.
Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany.
Clin Kidney J
; 16(1): 176-183, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726438
6.
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.
Eur J Heart Fail
; 25(3): 389-398, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36718652
7.
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland.
Pharmacoecon Open
; 6(5): 757-771, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35925491
8.
Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain.
Therap Adv Gastroenterol
; 15: 17562848221086131, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35574429
9.
Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK.
Clinicoecon Outcomes Res
; 13: 541-552, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34168471
10.
Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain.
Diabetes Ther
; 6(4): 593-610, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26589521
Resultados
1 -
10
de 10
1
Próxima >
>>